Thalidomide for the treatment of idiopathic myelofibrosis.
about
Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin's lymphoma: A prospective study of 46 cases.Profile of pomalidomide and its potential in the treatment of myelofibrosis.Primary myelofibrosis: current therapeutic options.Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.
P2860
Thalidomide for the treatment of idiopathic myelofibrosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Thalidomide for the treatment of idiopathic myelofibrosis.
@ast
Thalidomide for the treatment of idiopathic myelofibrosis.
@en
type
label
Thalidomide for the treatment of idiopathic myelofibrosis.
@ast
Thalidomide for the treatment of idiopathic myelofibrosis.
@en
prefLabel
Thalidomide for the treatment of idiopathic myelofibrosis.
@ast
Thalidomide for the treatment of idiopathic myelofibrosis.
@en
P2093
P2860
P1476
Thalidomide for the treatment of idiopathic myelofibrosis.
@en
P2093
Gattermann N
P2860
P356
10.1046/J.0902-4441.2003.00188.X
P577
2004-01-01T00:00:00Z